These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12184663)

  • 1. The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
    Jarosz PA; Metzger BL
    Biol Res Nurs; 2002 Apr; 3(4):198-209. PubMed ID: 12184663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.
    Jarosz PA
    Biol Res Nurs; 2007 Apr; 8(4):294-9. PubMed ID: 17456590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
    Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
    Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid regulation of food intake and body weight in humans.
    Atkinson RL
    Fed Proc; 1987 Jan; 46(1):178-82. PubMed ID: 3542577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor blockade promotes weight loss and improves the display of sexual behaviors in obese Zucker female rats.
    Marín-Bivens CL; Olster DH
    Pharmacol Biochem Behav; 1999 Jul; 63(3):515-20. PubMed ID: 10418795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.
    Cottone P; Sabino V; Steardo L; Zorrilla EP
    Neuropsychopharmacology; 2008 Feb; 33(3):524-35. PubMed ID: 17443124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of nalmefene on energy balance and glucose regulation in Zucker rats.
    McLaughlin CL; Baile CA; Gingerich RL; Michel ME
    Physiol Behav; 1986; 37(6):899-908. PubMed ID: 2947253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin delivery into the ventromedial nucleus of the hypothalamus affects differently feeding pattern and body weight in obese and lean Zucker rats.
    Fetissov SO; Meguid MM
    Appetite; 2010 Apr; 54(2):346-53. PubMed ID: 20060864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
    Smith SR; Blundell JE; Burns C; Ellero C; Schroeder BE; Kesty NC; Chen KS; Halseth AE; Lush CW; Weyer C
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E620-7. PubMed ID: 17505051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats.
    Cole JL; Berman N; Bodnar RJ
    Peptides; 1997; 18(8):1201-7. PubMed ID: 9396062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats.
    McLaughlin CL; Baile CA
    Pharmacol Biochem Behav; 1983 Aug; 19(2):235-40. PubMed ID: 6634872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats.
    Boggiano MM; Chandler PC; Viana JB; Oswald KD; Maldonado CR; Wauford PK
    Behav Neurosci; 2005 Oct; 119(5):1207-14. PubMed ID: 16300427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat.
    Shaw WN; Mitch CH; Leander JD; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):85-9. PubMed ID: 2329525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone for the treatment of obesity: review and update.
    Lee MW; Fujioka K
    Expert Opin Pharmacother; 2009 Aug; 10(11):1841-5. PubMed ID: 19537999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats.
    Kelley AE; Bless EP; Swanson CJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1499-507. PubMed ID: 8819538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin-concentrating hormone-1 receptor antagonism decreases feeding by reducing meal size.
    Kowalski TJ; Farley C; Cohen-Williams ME; Varty G; Spar BD
    Eur J Pharmacol; 2004 Aug; 497(1):41-7. PubMed ID: 15321733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats.
    Baptista T; Lacruz A; Acosta A; Colasante C; de Quijada M; de Mendoza S; Mendoza JM; Hernández L
    Appetite; 2000 Feb; 34(1):77-86. PubMed ID: 10744894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the kappa agonist PD-117302 on feeding behaviour in obese and lean Zucker rats.
    Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1988 Oct; 31(2):425-9. PubMed ID: 2854265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.